Form4insider filings, from the source

Insider holders · CIK 0001479290

Revance Therapeutics, Inc. · RVNC

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
L Daniel BrowneCEO and President168,943409169,352Feb 20, 2019 · 9:31 pm ESTForm 4
Ronald W EastmanDirector3,000117,458120,458May 12, 2017 · 7:47 pm EDTForm 4
Todd Erik ZavodnickCCO & President,96,407—96,407Oct 17, 2018 · 6:53 pm EDTForm 4
Abhay JoshiChief Operating Officer89,777—89,777Feb 20, 2019 · 9:33 pm ESTForm 4
Lauren P SilvernailCFO & CBO65,497—65,497May 24, 2018 · 7:24 pm EDTForm 4
Arthur Peter BertolinoEVP and Chief Medical Officer34,001—34,001Nov 17, 2015 · 9:45 pm ESTForm 4
Mark J FoleyDirector9,00020,00029,000May 11, 2018 · 8:26 pm EDTForm 4
Jacob WaughChief Scientific Officer28,413—28,413May 21, 2015 · 7:08 pm EDTForm 4
Caryn Gordon McDowellSVP, GC & Secretary24,318—24,318Jan 25, 2019 · 8:54 pm ESTForm 4
Curtis RueggEVP, Technical Operations23,944—23,944Jun 15, 2016 · 7:29 pm EDTForm 4
Tobin SchilkeCFO23,000—23,000Jan 25, 2019 · 9:00 pm ESTForm 4
Robert F ByrnesDirector6,00013,66519,665May 11, 2018 · 8:24 pm EDTForm 4
Philip J. VickersDirector9,150—9,150May 11, 2018 · 8:31 pm EDTForm 4
Cyril AllouchePrincipal Accounting Officer7,150—7,150Jan 25, 2019 · 8:51 pm ESTForm 4
Angus C. RussellDirector6,000—6,000May 11, 2018 · 8:30 pm EDTForm 4
Julian S GangolliDirector6,000—6,000May 11, 2018 · 8:27 pm EDTForm 4
Phyllis GardnerDirector6,000—6,000May 11, 2018 · 8:28 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.